<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38873474</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2048-7177</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Food science &amp; nutrition</Title><ISOAbbreviation>Food Sci Nutr</ISOAbbreviation></Journal><ArticleTitle>Effect of the combined intervention of low-FODMAPs diet and probiotics on IBS symptoms in Western China: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>3993</StartPage><EndPage>4004</EndPage><MedlinePgn>3993-4004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/fsn3.4057</ELocationID><Abstract><AbstractText>The effect of low-FODMAPs diet on irritable bowel syndrome (IBS) in Western China has not been reported. We aimed to investigate the effect of low-FODMAPs diet on IBS patients in the area and whether low-FODMAPs diet-induced alterations of microbiota could be improved through probiotics. IBS patients were randomized to the control group, low-FODMAPs diet group, probiotics group, or combined group. IBS Symptom Severity Score questionnaire (IBS-SSS) and IBS Quality of Life Score questionnaire (IBS-QOL) were completed at baseline, 2 and 4&#x2009;weeks to evaluate the severity of symptoms. Fresh feces were collected for analyses of gut microbiota and short-chain fatty acids at baseline and 4&#x2009;weeks after intervention. Seventy-three patients were included in the per protocol analysis. After intervention, there was significant improvement in IBS-SSS in the low-FODMAPs group (37.5%, 44.2%), probiotics group (51.4%, 62.0%), and combined group (34.1%, 40.4%) at both 2&#x2009;weeks and 4&#x2009;weeks, compared with the baseline (<i>p</i>&#x2009;&lt;&#x2009;.05). In the low-FODMAPs group, the abundance of several microbiota (<i>Lachnoclostridium</i>, <i>Enterococcus</i>, etc.) was significantly decreased. Furthermore, after the supplementation of probiotics in the combined group, the abundance of Genus_<i>Ruminococcus</i>, <i>Coprococcus</i>, <i>Acidaminococcus</i>, <i>Ruminiclostridium</i>, <i>Akkermansia</i>, <i>Eggerthella</i>, and <i>Oxalobacter</i> was significantly increased, which was associated with the improvements of symptoms score in the <i>Pearson</i> correlation analysis. Our study confirmed the effectiveness and safety of short-term low-FODMAPs diet in IBS symptoms based on the Chinese diet in Western China. The combination of low-FODMAPs and probiotics plays a beneficial role in gut microbiota in IBS.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Food Science &amp; Nutrition published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0005-0459-9107</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology West China Hospital, Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Urology West China Hospital of Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology West China Hospital, Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition West China Hospital, Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Limei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology West China Hospital, Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Lei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1330-6039</Identifier><AffiliationInfo><Affiliation>Department of Clinical Nutrition West China Hospital, Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6413-708X</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology West China Hospital, Sichuan University Chengdu China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Food Sci Nutr</MedlineTA><NlmUniqueID>101605473</NlmUniqueID><ISSNLinking>2048-7177</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Western China</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">low&#x2010;FODMAPs diet</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38873474</ArticleId><ArticleId IdType="pmc">PMC11167163</ArticleId><ArticleId IdType="doi">10.1002/fsn3.4057</ArticleId><ArticleId IdType="pii">FSN34057</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alammar, N. , &amp; Stein, E. (2019). Irritable bowel syndrome: What treatments really work. The Medical Clinics of North America, 103(1), 137&#x2013;152. 10.1016/j.mcna.2018.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2018.08.006</ArticleId><ArticleId IdType="pubmed">30466670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaldo, E. , Slayden, L. C. , Ching, K. L. , Koch, M. A. , Wolf, N. K. , Plichta, D. R. , Brown, E. M. , Graham, D. B. , Xavier, R. J. , Moon, J. J. , &amp; Barton, G. M. (2019). Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science (New York, N.Y.), 364(6446), 1179&#x2013;1184. 10.1126/science.aaw7479</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw7479</ArticleId><ArticleId IdType="pmc">PMC6645389</ArticleId><ArticleId IdType="pubmed">31221858</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett, J. S. , Gearry, R. B. , Muir, J. G. , Irving, P. M. , Rose, R. , Rosella, O. , Haines, M. L. , Shepherd, S. J. , &amp; Gibson, P. R. (2010). Dietary poorly absorbed, short&#x2010;chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Alimentary Pharmacology &amp; Therapeutics, 31(8), 874&#x2013;882. 10.1111/j.1365-2036.2010.04237.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2010.04237.x</ArticleId><ArticleId IdType="pubmed">20102355</ArticleId></ArticleIdList></Reference><Reference><Citation>Biesiekierski, J. R. , Rosella, O. , Rose, R. , Liels, K. , Barrett, J. S. , Shepherd, S. J. , Gibson, P. R. , &amp; Muir, J. G. (2011). Quantification of fructans, galacto&#x2010;oligosacharides and other short&#x2010;chain carbohydrates in processed grains and cereals. Journal of Human Nutrition and Dietetics, 24(2), 154&#x2013;176. 10.1111/j.1365-277X.2010.01139.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-277X.2010.01139.x</ArticleId><ArticleId IdType="pubmed">21332832</ArticleId></ArticleIdList></Reference><Reference><Citation>Black, C. J. , &amp; Ford, A. C. (2020). Global burden of irritable bowel syndrome: Trends, predictions and risk factors. Nature Reviews. Gastroenterology &amp; Hepatology, 17(8), 473&#x2013;486. 10.1038/s41575-020-0286-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-020-0286-8</ArticleId><ArticleId IdType="pubmed">32296140</ArticleId></ArticleIdList></Reference><Reference><Citation>Black, C. J. , Staudacher, H. M. , &amp; Ford, A. C. (2022). Efficacy of a low FODMAP diet in irritable bowel syndrome: Systematic review and network meta&#x2010;analysis. Gut, 71(6), 1117&#x2013;1126. 10.1136/gutjnl-2021-325214</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325214</ArticleId><ArticleId IdType="pubmed">34376515</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri, M. , &amp; Dilmaghani, S. (2023). Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review. Pharmacology &amp; Therapeutics, 245, 108400. 10.1016/j.pharmthera.2023.108400</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2023.108400</ArticleId><ArticleId IdType="pubmed">37001737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahwan, B. , Kwan, S. , Isik, A. , van Hemert, S. , Burke, C. , &amp; Roberts, L. (2019). Gut feelings: A randomised, triple&#x2010;blind, placebo&#x2010;controlled trial of probiotics for depressive symptoms. Journal of Affective Disorders, 253, 317&#x2013;326. 10.1016/j.jad.2019.04.097</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2019.04.097</ArticleId><ArticleId IdType="pubmed">31078831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chey, W. D. , Hashash, J. G. , Manning, L. , &amp; Chang, L. (2022). AGA clinical practice update on the role of diet in irritable bowel syndrome: Expert review. Gastroenterology, 162(6), 1737&#x2013;1745.e5. 10.1053/j.gastro.2021.12.248</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.12.248</ArticleId><ArticleId IdType="pubmed">35337654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chojnacki, C. , Poplawski, T. , Blonska, A. , Konrad, P. , Chojnacki, J. , &amp; Blasiak, J. (2023). The usefulness of the low&#x2010;FODMAP diet with limited tryptophan intake in the treatment of diarrhea&#x2010;predominant irritable bowel syndrome. Nutrients, 15(8), 1837. 10.3390/nu15081837</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15081837</ArticleId><ArticleId IdType="pmc">PMC10145220</ArticleId><ArticleId IdType="pubmed">37111056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumpitazi, B. P. , Lim, J. , McMeans, A. R. , Shulman, R. J. , &amp; Hamaker, B. R. (2018). Evaluation of FODMAP carbohydrates content in selected foods in the United States. The Journal of Pediatrics, 199, 252&#x2013;255. 10.1016/j.jpeds.2018.03.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2018.03.038</ArticleId><ArticleId IdType="pmc">PMC6063767</ArticleId><ArticleId IdType="pubmed">29706489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong, J. , Zhou, P. , &amp; Zhang, R. (2022). Intestinal microbiota&#x2010;derived short chain fatty acids in host health and disease. Nutrients, 14(9), 1977. 10.3390/nu14091977</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14091977</ArticleId><ArticleId IdType="pmc">PMC9105144</ArticleId><ArticleId IdType="pubmed">35565943</ArticleId></ArticleIdList></Reference><Reference><Citation>Depommier, C. , Everard, A. , Druart, C. , Plovier, H. , Van Hul, M. , Vieira&#x2010;Silva, S. , Falony, G. , Raes, J. , Maiter, D. , Delzenne, N. M. , de Barsy, M. , Loumaye, A. , Hermans, M. P. , Thissen, J.&#x2010;P. , de Vos, W. M. , &amp; Cani, P. D. (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof&#x2010;of&#x2010;concept exploratory study. Nature Medicine, 25(7), 1096&#x2013;1103. 10.1038/s41591-019-0495-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0495-2</ArticleId><ArticleId IdType="pmc">PMC6699990</ArticleId><ArticleId IdType="pubmed">31263284</ArticleId></ArticleIdList></Reference><Reference><Citation>Drossman, D. A. , &amp; Hasler, W. L. (2016). Rome IV&#x2010;functional GI disorders: Disorders of gut&#x2010;brain interaction. Gastroenterology, 150(6), 1257&#x2013;1261. 10.1053/j.gastro.2016.03.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.03.035</ArticleId><ArticleId IdType="pubmed">27147121</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan, R. , Zhu, S. , Wang, B. , &amp; Duan, L. (2019). Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA&#x2010;targeted sequencing: A systematic review. Clinical and Translational Gastroenterology, 10(2), e00012. 10.14309/ctg.0000000000000012</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000012</ArticleId><ArticleId IdType="pmc">PMC6407812</ArticleId><ArticleId IdType="pubmed">30829919</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis, C. Y. , Morris, J. , &amp; Whorwell, P. J. (1997). The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacology &amp; Therapeutics, 11(2), 395&#x2013;402. 10.1046/j.1365-2036.1997.142318000.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.1997.142318000.x</ArticleId><ArticleId IdType="pubmed">9146781</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou, K. , Wu, Z.&#x2010;X. , Chen, X.&#x2010;Y. , Wang, J.&#x2010;Q. , Zhang, D. , Xiao, C. , Zhu, D. , Koya, J. B. , Wei, L. , Li, J. , &amp; Chen, Z.&#x2010;S. (2022). Microbiota in health and diseases. Signal Transduction and Targeted Therapy, 7(1), 135. 10.1038/s41392-022-00974-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao, W. , Zhang, Z. , Xu, Y. , Gong, L. , Zhang, W. , Tang, H. , Zeng, S. , Zhang, Q. , Sun, Z. , Liu, L. , &amp; Hu, X. (2020). Butyric acid normalizes hyperglycemia caused by the tacrolimus&#x2010;induced gut microbiota. American Journal of Transplantation, 20(9), 2413&#x2013;2424. 10.1111/ajt.15880</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15880</ArticleId><ArticleId IdType="pubmed">32243709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaakoush, N. O. (2020). Sutterella species, IgA&#x2010;degrading bacteria in ulcerative colitis. Trends in Microbiology, 28(7), 519&#x2013;522. 10.1016/j.tim.2020.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.02.018</ArticleId><ArticleId IdType="pubmed">32544438</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampik, C. , Liu, N. , Mroueh, M. , Franche, N. , Borne, R. , Denis, Y. , Gagnot, S. , Tardif, C. , Pag&#xe8;s, S. , Perret, S. , Vita, N. , de Philip, P. , &amp; Fierobe, H.&#x2010;P. (2021). Handling several sugars at a time: A case study of xyloglucan utilization by Ruminiclostridium cellulolyticum . MBio, 12(6), e0220621. 10.1128/mBio.02206-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02206-21</ArticleId><ArticleId IdType="pmc">PMC8576529</ArticleId><ArticleId IdType="pubmed">34749527</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, C. H. (2021). Control of lymphocyte functions by gut microbiota&#x2010;derived short&#x2010;chain fatty acids. Cellular &amp; Molecular Immunology, 18(5), 1161&#x2013;1171. 10.1038/s41423-020-00625-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00625-0</ArticleId><ArticleId IdType="pmc">PMC8093302</ArticleId><ArticleId IdType="pubmed">33850311</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacy, B. E. , Pimentel, M. , Brenner, D. M. , Chey, W. D. , Keefer, L. A. , Long, M. D. , &amp; Moshiree, B. (2021). ACG clinical guideline: Management of irritable bowel syndrome. The American Journal of Gastroenterology, 116(1), 17&#x2013;44. 10.14309/ajg.0000000000001036</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001036</ArticleId><ArticleId IdType="pubmed">33315591</ArticleId></ArticleIdList></Reference><Reference><Citation>Makki, K. , Deehan, E. C. , Walter, J. , &amp; B&#xe4;ckhed, F. (2018). The impact of dietary fiber on gut microbiota in host health and disease. Cell Host &amp; Microbe, 23(6), 705&#x2013;715. 10.1016/j.chom.2018.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.05.012</ArticleId><ArticleId IdType="pubmed">29902436</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh, K. , Reed, D. E. , Schneider, T. , Dang, F. , Keshteli, A. H. , De Palma, G. , Madsen, K. , Bercik, P. , &amp; Vanner, S. (2017). FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut, 66(7), 1241&#x2013;1251. 10.1136/gutjnl-2015-311339</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2015-311339</ArticleId><ArticleId IdType="pubmed">26976734</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir, J. G. , Rose, R. , Rosella, O. , Liels, K. , Barrett, J. S. , Shepherd, S. J. , &amp; Gibson, P. R. (2009). Measurement of short&#x2010;chain carbohydrates in common Australian vegetables and fruits by high&#x2010;performance liquid chromatography (HPLC). Journal of Agricultural and Food Chemistry, 57(2), 554&#x2013;565. 10.1021/jf802700e</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf802700e</ArticleId><ArticleId IdType="pubmed">19123815</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir, J. G. , Shepherd, S. J. , Rosella, O. , Rose, R. , Barrett, J. S. , &amp; Gibson, P. R. (2007). Fructan and free fructose content of common Australian vegetables and fruit. Journal of Agricultural and Food Chemistry, 55(16), 6619&#x2013;6627. 10.1021/jf070623x</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf070623x</ArticleId><ArticleId IdType="pubmed">17625872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong, D. K. , Mitchell, S. B. , Barrett, J. S. , Shepherd, S. J. , Irving, P. M. , Biesiekierski, J. R. , Smith, S. , Gibson, P. R. , &amp; Muir, J. G. (2010). Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. Journal of Gastroenterology and Hepatology, 25(8), 1366&#x2013;1373. 10.1111/j.1440-1746.2010.06370.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.2010.06370.x</ArticleId><ArticleId IdType="pubmed">20659225</ArticleId></ArticleIdList></Reference><Reference><Citation>Patcharatrakul, T. , Juntrapirat, A. , Lakananurak, N. , &amp; Gonlachanvit, S. (2019). Effect of structural individual low&#x2010;FODMAP dietary advice vs. brief advice on a commonly recommended diet on IBS symptoms and intestinal gas production. Nutrients, 11(12), 2856. 10.3390/nu11122856</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11122856</ArticleId><ArticleId IdType="pmc">PMC6950148</ArticleId><ArticleId IdType="pubmed">31766497</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick, D. L. , Drossman, D. A. , Frederick, I. O. , DiCesare, J. , &amp; Puder, K. L. (1998). Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure. Digestive Diseases and Sciences, 43(2), 400&#x2013;411. 10.1023/a:1018831127942</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1018831127942</ArticleId><ArticleId IdType="pubmed">9512138</ArticleId></ArticleIdList></Reference><Reference><Citation>Prichard, R. , Rossi, M. , Muir, J. , Yao, C. , Whelan, K. , &amp; Lomer, M. (2016). Fermentable oligosaccharide, disaccharide, monosaccharide and polyol content of foods commonly consumed by ethnic minority groups in the United Kingdom. International Journal of Food Sciences and Nutrition, 67(4), 383&#x2013;390. 10.3109/09637486.2016.1163328</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09637486.2016.1163328</ArticleId><ArticleId IdType="pubmed">27002546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rej, A. , Avery, A. , Aziz, I. , Black, C. J. , Bowyer, R. K. , Buckle, R. L. , Seamark, L. , Shaw, C. C. , Thompson, J. , Trott, N. , Williams, M. , &amp; Sanders, D. S. (2022). Diet and irritable bowel syndrome: An update from a UK consensus meeting. BMC Medicine, 20(1), 287. 10.1186/s12916-022-02496-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02496-w</ArticleId><ArticleId IdType="pmc">PMC9469508</ArticleId><ArticleId IdType="pubmed">36096789</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann, D. , Klose, P. , Lauche, R. , Dobos, G. , Langhorst, J. , &amp; Cramer, H. (2018). Low fermentable, oligo&#x2010;, di&#x2010;, mono&#x2010;saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta&#x2010;analysis. Nutrition (Burbank, Los Angeles County, Calif.), 45, 24&#x2013;31. 10.1016/j.nut.2017.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2017.07.004</ArticleId><ArticleId IdType="pubmed">29129233</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, E. , C&#x103;linoiu, L. F. , Mitrea, L. , &amp; Vodnar, D. C. (2021). Probiotics, prebiotics, and synbiotics: Implications and beneficial effects against irritable bowel syndrome. Nutrients, 13(6), 2112. 10.3390/nu13062112</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13062112</ArticleId><ArticleId IdType="pmc">PMC8233736</ArticleId><ArticleId IdType="pubmed">34203002</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, V. , Lee, G. , Son, H. , Koh, H. , Kim, E. S. , Unno, T. , &amp; Shin, J.&#x2010;H. (2023). Butyrate producers, &#x201c;the sentinel of gut&#x201d;: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Frontiers in Microbiology, 13, 1103836. 10.3389/fmicb.2022.1103836</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1103836</ArticleId><ArticleId IdType="pmc">PMC9877435</ArticleId><ArticleId IdType="pubmed">36713166</ArticleId></ArticleIdList></Reference><Reference><Citation>So, D. , Loughman, A. , &amp; Staudacher, H. M. (2022). Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: A systematic review with meta&#x2010;analysis. The American Journal of Clinical Nutrition, 116(4), 943&#x2013;952. 10.1093/ajcn/nqac176</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqac176</ArticleId><ArticleId IdType="pmc">PMC9535515</ArticleId><ArticleId IdType="pubmed">35728042</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudacher, H. M. , Lomer, M. C. E. , Farquharson, F. M. , Louis, P. , Fava, F. , Franciosi, E. , Scholz, M. , Tuohy, K. M. , Lindsay, J. O. , Irving, P. M. , &amp; Whelan, K. (2017). A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: A randomized controlled trial. Gastroenterology, 153(4), 936&#x2013;947. 10.1053/j.gastro.2017.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.06.010</ArticleId><ArticleId IdType="pubmed">28625832</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudacher, H. M. , Rossi, M. , Kaminski, T. , Dimidi, E. , Ralph, F. S. E. , Wilson, B. , Martin, L. D. , Louis, P. , Lomer, M. C. E. , Irving, P. M. , &amp; Whelan, K. (2022). Long&#x2010;term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterology and Motility, 34(4), e14241. 10.1111/nmo.14241</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14241</ArticleId><ArticleId IdType="pubmed">34431172</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudacher, H. M. , Scholz, M. , Lomer, M. C. , Ralph, F. S. , Irving, P. M. , Lindsay, J. O. , Fava, F. , Tuohy, K. , &amp; Whelan, K. (2021). Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clinical Nutrition (Edinburgh, Scotland), 40(4), 1861&#x2013;1870. 10.1016/j.clnu.2020.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.10.013</ArticleId><ArticleId IdType="pubmed">33183883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuck, C. , Ly, E. , Bogatyrev, A. , Costetsou, I. , Gibson, P. , Barrett, J. , &amp; Muir, J. (2018). Fermentable short chain carbohydrate (FODMAP) content of common plant&#x2010;based foods and processed foods suitable for vegetarian&#x2010; and vegan&#x2010;based eating patterns. Journal of Human Nutrition and Dietetics, 31(3), 422&#x2013;435. 10.1111/jhn.12546</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhn.12546</ArticleId><ArticleId IdType="pubmed">29473657</ArticleId></ArticleIdList></Reference><Reference><Citation>van Lanen, A.&#x2010;S. , de Bree, A. , &amp; Greyling, A. (2021). Efficacy of a low&#x2010;FODMAP diet in adult irritable bowel syndrome: A systematic review and meta&#x2010;analysis. European Journal of Nutrition, 60(6), 3505&#x2013;3522. 10.1007/s00394-020-02473-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-020-02473-0</ArticleId><ArticleId IdType="pmc">PMC8354978</ArticleId><ArticleId IdType="pubmed">33585949</ArticleId></ArticleIdList></Reference><Reference><Citation>Varney, J. , Barrett, J. , Scarlata, K. , Catsos, P. , Gibson, P. R. , &amp; Muir, J. G. (2017). FODMAPs: Food composition, defining cutoff values and international application. Journal of Gastroenterology and Hepatology, 32(Suppl 1), 53&#x2013;61. 10.1111/jgh.13698</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.13698</ArticleId><ArticleId IdType="pubmed">28244665</ArticleId></ArticleIdList></Reference><Reference><Citation>Vervier, K. , Moss, S. , Kumar, N. , Adoum, A. , Barne, M. , Browne, H. , Kaser, A. , Kiely, C. J. , Neville, B. A. , Powell, N. , Raine, T. , Stares, M. D. , Zhu, A. , De La Revilla Negro, J. , Lawley, T. D. , &amp; Parkes, M. (2022). Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut, 71(9), 1821&#x2013;1830. 10.1136/gutjnl-2021-325177</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325177</ArticleId><ArticleId IdType="pmc">PMC9380505</ArticleId><ArticleId IdType="pubmed">34810234</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson, B. , Kanno, T. , Slater, R. , Rossi, M. , Irving, P. M. , Lomer, M. C. , Probert, C. , Mason, A. J. , &amp; Whelan, K. (2023). Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics, 58(4), 404&#x2013;416. 10.1111/apt.17609</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.17609</ArticleId><ArticleId IdType="pubmed">37313992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson, B. , Rossi, M. , Kanno, T. , Parkes, G. C. , Anderson, S. , Mason, A. J. , Irving, P. M. , Lomer, M. C. , &amp; Whelan, K. (2020). &#x3b2;&#x2010;Galactooligosaccharide in conjunction with low FODMAP diet improves irritable bowel syndrome symptoms but reduces fecal Bifidobacteria . The American Journal of Gastroenterology, 115(6), 906&#x2013;915. 10.14309/ajg.0000000000000641</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000641</ArticleId><ArticleId IdType="pubmed">32433273</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, R. , Shan, S. , Shi, J. , Li, H. , An, N. , Li, S. , Cui, K. , Guo, H. , &amp; Li, Z. (2023). Coprococcus eutactus, a potent probiotic, alleviates colitis via acetate&#x2010;mediated IgA response and microbiota restoration. Journal of Agricultural and Food Chemistry, 71(7), 3273&#x2013;3284. 10.1021/acs.jafc.2c06697</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.2c06697</ArticleId><ArticleId IdType="pubmed">36786768</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoman, C. J. , Fields, C. J. , Lepercq, P. , Ruiz, P. , Forano, E. , White, B. A. , &amp; Mosoni, P. (2021). In vivo competitions between Fibrobacter succinogenes, Ruminococcus flavefaciens, and Ruminoccus albus in a gnotobiotic sheep model revealed by multi&#x2010;omic analyses. MBio, 12(2), e03533&#x2010;20. 10.1128/mBio.03533-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03533-20</ArticleId><ArticleId IdType="pmc">PMC8092306</ArticleId><ArticleId IdType="pubmed">33658330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. , Feng, L. , Wang, X. , Fox, M. , Luo, L. , Du, L. , Chen, B. , Chen, X. , He, H. , Zhu, S. , Hu, Z. , Chen, S. , Long, Y. , Zhu, Y. , Xu, L. , Deng, Y. , Misselwitz, B. , Lang, B. M. , Yilmaz, B. , &#x2026; Dai, N. (2021). Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea&#x2010;predominant irritable bowel syndrome: A parallel&#x2010;group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes. The American Journal of Clinical Nutrition, 113(6), 1531&#x2013;1545. 10.1093/ajcn/nqab005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqab005</ArticleId><ArticleId IdType="pubmed">33740048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Z. , Liu, L. , Tang, H. , Jiao, W. , Zeng, S. , Xu, Y. , Zhang, Q. , Sun, Z. , Mukherjee, A. , Zhang, X. , &amp; Hu, X. (2018). Immunosuppressive effect of the gut microbiome altered by high&#x2010;dose tacrolimus in mice. American Journal of Transplantation, 18(7), 1646&#x2013;1656. 10.1111/ajt.14661</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.14661</ArticleId><ArticleId IdType="pubmed">29316256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>